CKD-516 displays vascular disrupting properties and enhances anti-tumor activity in combination with chemotherapy in a murine tumor model.

about

Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors.Enhanced efficacy of radiofrequency ablation for hepatocellular carcinoma using a novel vascular disrupting agent, CKD-516.

P2860

Q36482522-41D7B0C2-745D-431A-8CF3-5B41BA481F91 Q52683090-555EC194-C0EC-4F22-9D8E-74C5DBDE4674

P2860

CKD-516 displays vascular disrupting properties and enhances anti-tumor activity in combination with chemotherapy in a murine tumor model.

Item

http://www.wikidata.org/entity/Q38445000

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

CKD-516 displays vascular disr ...... erapy in a murine tumor model.

@en

type

Item

label

CKD-516 displays vascular disr ...... erapy in a murine tumor model.

@en

prefLabel

CKD-516 displays vascular disr ...... erapy in a murine tumor model.

@en

P1476

CKD-516 displays vascular disr ...... erapy in a murine tumor model.

@en

P2093

Chang Hoon Moon

http://www.w3.org/2001/XMLSchema#string

HeeJeong Cha

http://www.w3.org/2001/XMLSchema#string

Ho Yong Lee

http://www.w3.org/2001/XMLSchema#string

Jeong Woo Park

http://www.w3.org/2001/XMLSchema#string

Le Thi Kim Dung

http://www.w3.org/2001/XMLSchema#string

Seung Ju Lee

http://www.w3.org/2001/XMLSchema#string

Wha Ja Cho

http://www.w3.org/2001/XMLSchema#string

Young Joo Min

http://www.w3.org/2001/XMLSchema#string

P2860

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

What is the evidence that tumors are angiogenesis dependent?

Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics.

Characterization of isotype-specific regions of five classes of canine beta-tubulin and their expression in several tissues and cell culture.

Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes.

KML001 displays vascular disrupting properties and irinotecan combined antitumor activities in a murine tumor model.

Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study

Vascular targeting agents as cancer therapeutics.

Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies.

Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery.

P2888

s10637-013-0043-8

P304

400-411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10637-013-0043-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1035388783

http://www.w3.org/2001/XMLSchema#string

P698

24202729

http://www.w3.org/2001/XMLSchema#string

CKD-516 displays vascular disrupting properties and enhances anti-tumor activity in combination with chemotherapy in a murine tumor model.

about

P2860

P2860

CKD-516 displays vascular disrupting properties and enhances anti-tumor activity in combination with chemotherapy in a murine tumor model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698